Patent ID: 7592454

Claim:
A compound according to Formula (I): including all stereoisomers, and pharmaceutically acceptable salt forms thereof, wherein: X is selected from the group consisting of —S—, —S(═O)—, —S(═O) 2 — and —NR 10 —; R 1 is selected from the group consisting of H, C 3-7 cycloalkyl, C 1-3 haloalkyl, and C 1-4 alkyl substituted with 0-3 R 2 ; R 2 , at each occurrence, is independently selected from halo, C 1-3 haloalkyl, C 1-4 alkoxy, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, and aryl substituted with 0-5 R 21 ; R 4a is selected from the group consisting of H and C 1-4 alkyl; R 5 is selected from the group consisting of H, C 1-4 alkyl; R 6 is selected from the group consisting of —CF 3 , C 1-6 alkyl, and aryl substituted with 0-5 R 21 ; R 7 , R 8 , and R 9 are H; R 10 is H or C 1-4 alkyl; R 21 , at each occurrence, is independently selected from H, OH, halo, CF 3 , SO 2 R 45 , NR 46 R 47 , CN, NO 2 , C 1-4 alkyl; C 2-8 alkenyl, C 2-8 alkynyl, C 1-4 alkoxy, and C 1-4 haloalkyl; R 45 is C 1-4 alkyl; R 46 , at each occurrence, is independently selected from H and C 1-4 alkyl; R 47 , at each occurrence, is independently selected from H, and C 1-4 alkyl; and m is 1.